Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Takeda
Takeda
Years after Sanofi's Dengvaxia fiasco, Takeda lands first OK for its own dengue vaccine
Endpoints
Tue, 08/23/22 - 10:27 am
Takeda
dengue
vaccines
WHO
TAK-003
Qdenga
Indonesia
Flush with $126M raise, Tessa Therapeutics woos new CEO from Takeda
Endpoints
Mon, 08/22/22 - 10:04 am
Tessa Therapeutics
Takeda
Thomas Willemsen
CAR-T
Pharma CEOs
Takeda cuts ties to cancer drug landed in $120M Turnstone deal
Fierce Biotech
Thu, 07/28/22 - 10:59 am
Takeda
narcolepsy
TAK-994
TAK-605
Turnstone Biologics
A year after netting Takeda partnership, small molecule startup arms itself with some new cash
Endpoints
Wed, 07/27/22 - 10:52 am
startups
BridGene Biosciences
Takeda
funding
Eli Lilly
Ascletis, Takeda, Arrowhead & More Present New Findings at EASL Liver Conference
BioSpace
Tue, 06/28/22 - 10:49 am
EASL
liver disease
Ascletis
Takeda
Arrowhead Pharmaceuticals
Takeda to further cement presence in Cambridge, MA biopharma hub with 600,000-square-foot R&D center
Endpoints
Wed, 06/22/22 - 10:30 am
Takeda
biotech hubs
Cambridge MA
R&D
Takeda’s Dengue Fever Vaccine Holds Up Over 4.5 Years
BioSpace
Thu, 06/9/22 - 10:38 am
Takeda
TAK-003
vaccines
dengue
clinical trials
Two Remarkable Women of Takeda's C-Suite Make the Professional Personal
BioSpace
Thu, 06/9/22 - 10:17 am
Takeda
women executives
Ramona Sequeira
Julie Kim
A ‘perfect storm’ of world calamities may bring down drug prices, Takeda CEO says
Fierce Pharma
Thu, 06/2/22 - 10:28 am
Takeda
Pharma CEOs
Christophe Weber
drug prices
climate change
COVID-19
Ukraine
Moderna and Takeda Announce Plans to Transfer Marketing Authorization for Spikevax(TM) COVID-19 Vaccine in Japan to Moderna
BioSpace
Tue, 05/31/22 - 10:32 am
Moderna Therapeutics
Takeda
Japan
vaccines
COVID-19
ASCO: Seagen, Takeda think Adcetris can become a force as a lymphoma combo drug
Fierce Pharma
Fri, 05/27/22 - 10:31 am
ASCO 2022
Seagen
Takeda
Adcetris
lymphoma
Ex-Takeda exec hits the ground running at the helm of rare disease biotech — with 3 priorities off the bat
Endpoints
Fri, 05/20/22 - 10:34 am
Takeda
Tauhid Ali
rare disease
Oak Hill Bio
Takeda Drops One Hunter Syndrome Therapeutic, Puts Faith in Another
BioSpace
Thu, 05/12/22 - 10:21 am
Takeda
earnings
TAK-609
Hunter Syndrome
Takeda, bracing for Vyvanse patent loss, makes strides on debt goal and pivots its focus to launches
Fierce Pharma
Wed, 05/11/22 - 10:49 am
Takeda
debt
Vyvanse
patents
earnings
All Takeda wants for its billion-dollar gene therapy spending spree is functional cures
Fierce Biotech
Wed, 05/4/22 - 10:20 am
Takeda
gene therapy
rare disease
HilleVax’s IPO hauls in $200M for clinical test of VLP norovirus vaccine from Takeda
MedCity News
Mon, 05/2/22 - 11:46 am
IPOs
vaccines
HilleVax
Takeda
norovirus
Takeda/Evozyne Partnership Headlines Hot Week for Gene Therapy Deals
BioSpace
Wed, 04/6/22 - 07:37 pm
Takeda
Evozyne
gene therapy
Rare Diseases
Takeda's gene therapy hunger not yet quelled as Evozyne pact extended for $400M in biobucks
Fierce Biotech
Tue, 04/5/22 - 11:13 am
Takeda
gene therapy
Evozyne
R&D
Return of Takeda’s Parathyroid Hormone Injection Delayed Indefinitely
BioSpace
Tue, 03/22/22 - 11:16 pm
Takeda
parathyroid
hypoparathyroidism
Natpara
FDA
After price deal, Takeda's lung cancer drug Exkivity wins UK green light ahead of J&J rival
Fierce Pharma
Mon, 03/21/22 - 10:33 pm
Takeda
JNJ
Exkivity
non-small cell lung cancer
UK
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »